Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Prevention and treatment of MS: studying the effects of vitamin D.
[The Sjögren's syndrome and multiple sclerosis: similarity and differences.]
Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
Laquinimod - New Promising Treatment for Multiple Sclerosis
Ceramide Synthase 6 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis.
Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.
A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity.
A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging.
Receptos, Inc. - Current Report: United States Securities and Exchange Commission Form 8-K
Transverse myelitis -- a review of the presentation, diagnosis, and initial management.
Helminth therapy and multiple sclerosis.
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.
Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.
Punctate pattern: A promising imaging marker for the diagnosis of natalizumab-associated PML.
Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis.
Pilates based core stability training in ambulant individuals with multiple sclerosis: Protocol for a multi-centre randomised controlled trial.
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment.
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis.
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes.
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level.
High dose thiamine improves fatigue in multiple sclerosis.
Pages
« first
‹ previous
…
137
138
139
140
141
142
143
144
145
…
next ›
last »